FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Emtriva (emtricitabine) to update its labeling, reflecting changes approved for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Viral Hepatitis

Drugs mentioned

• Emtriva (emtricitabine)

Snippet

SUPPL AP for EMTRIVA (EMTRICITABINE)